Silexion Therapeutics Corp(SLXN)
0.3932+0.0437+12.50%
行情数据延迟15分钟
- 最新
- 推荐
暂无内容公司概况
公司名称Silexion Therapeutics Corp所属市场NASDAQ成立日期- -员工人数- -办公地址- -邮政编码- -联系电话- -联系传真- -公司概况Silexion Therapeutics Corp是一家开曼群岛豁免公司。该公司是一家临床阶段、专注于肿瘤学的生物技术公司，致力于开发针对KRAS突变驱动的癌症的专有疗法。其主要候选药物SIL204是一种旨在抑制突变KRAS蛋白产生的第二代小干扰RNA，最初针对局部晚期胰腺癌。- 08-21Form 8-K - Current report重要事件披露Form 8-K - Current report
- 08-18Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors超过5%披露Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
- 08-14Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 08-14Form 8-K - Current report重要事件披露Form 8-K - Current report
- 08-13Form 8-K - Current report重要事件披露Form 8-K - Current report
- 08-13Form 8-K - Current report重要事件披露Form 8-K - Current report
- 08-13Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]超过5%披露Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 08-10Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend][修订]招股说明书Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
- 08-10Form 8-K - Current report重要事件披露Form 8-K - Current report
- 08-08Form S-1 - General form for registration of securities under the Securities Act of 1933招股说明书Form S-1 - General form for registration of securities under the Securities Act of 1933
- 08-05Form 8-K - Current report重要事件披露Form 8-K - Current report
- 08-03Form 8-K - Current report重要事件披露Form 8-K - Current report
- 07-31Form 8-K - Current report重要事件披露Form 8-K - Current report
- 07-30Form 8-K - Current report重要事件披露Form 8-K - Current report
- 07-22Form 8-K - Current report重要事件披露Form 8-K - Current report
- 分时
- 5日
- 日
- 周
- 月
数据加载中...
最高
0.4859
今开
0.4123
量比
1033.19
最低
0.3849
昨收
0.3495
换手率
2028.39%